GlassScriptPhysician profile
Olger Nano
NPI 1235587312
$4,123.50
in general payments reported to CMS, 2019-2025
27 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $547 · 2022: $1,288 · 2023: $1,017 · 2024: $801 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Education: $87.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.22 |
| Education | $87.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $465.44 | 2022-2024 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $255.41 | 2022-2025 | Tagrisso, Imfinzi |
| Blueprint Medicines Corporation | $250.76 | 2021-2022 | |
| Genentech USA, INC. | $229.90 | 2022-2023 | Tecentriq |
| Genzyme Corporation | $224.47 | 2022-2023 | |
| Novocure INC. | $218.54 | 2024 | Optune, Optune Lua (Novottf-200t) |
| Incyte Corporation | $206.60 | 2022-2023 | Jakafi |
| Seagen INC. | $206.08 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $192.06 | 2021-2023 | Libtayo |
| Lilly USA, LLC | $184.36 | 2021-2024 | |
| Janssen Scientific Affairs, LLC | $130.80 | 2024 | Rybrevant |
| Jazz Pharmaceuticals INC. | $125.00 | 2022 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| G1 Therapeutics, INC. | $125.00 | 2023 | Cosela |
| Amgen INC. | $124.99 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $122.55 | 2024 | Ogsiveo |
| Rigel Pharmaceuticals, INC. | $121.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.45 | 2023 | |
| Astellas Pharma US INC | $110.94 | 2022 | |
| Beone Medicines USA, INC. | $110.32 | 2025 | Brukinsa |
| Servier Pharmaceuticals LLC | $107.85 | 2024 | |
| Kite Pharma, INC. | $100.00 | 2021 | |
| Pfizer INC. | $84.31 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.73 | 2025 | Alunbrig |
| Sirtex Medical INC | $46.05 | 2022 | |
| Daiichi Sankyo INC. | $42.74 | 2022-2025 | Enhertu |
| Teleflex LLC | $34.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olger Nano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.